These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 2426934)
1. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin. Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934 [TBL] [Abstract][Full Text] [Related]
2. Objective assessment of heparin requirements for hemodialysis in humans. Ireland H; Lane DA; Curtis JR J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409 [TBL] [Abstract][Full Text] [Related]
3. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. Mombelli G; Im Hof V; Haeberli A; Straub PW Circulation; 1984 Apr; 69(4):684-9. PubMed ID: 6697455 [TBL] [Abstract][Full Text] [Related]
4. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Rosove MH; Frank HJ; Harwig SS Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689 [TBL] [Abstract][Full Text] [Related]
5. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074 [TBL] [Abstract][Full Text] [Related]
6. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator. Rapold HJ; Kuemmerli H; Weiss M; Baur H; Haeberli A Circulation; 1989 May; 79(5):980-9. PubMed ID: 2496939 [TBL] [Abstract][Full Text] [Related]
7. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain. Douglas JT; Lowe GD; Forbes CD; Prentice CR Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751 [TBL] [Abstract][Full Text] [Related]
8. [Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction]. Cassetti M; Palazzesi G; Materazzi M; Massoli PD Quad Sclavo Diagn; 1985 Jun; 21(2):173-81. PubMed ID: 2417270 [TBL] [Abstract][Full Text] [Related]
9. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease. Rosove MH; Hocking WG; Harwig SS; Perloff JK Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239 [TBL] [Abstract][Full Text] [Related]
10. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation. Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807 [TBL] [Abstract][Full Text] [Related]
11. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group. Rapold HJ; de Bono D; Arnold AE; Arnout J; De Cock F; Collen D; Verstraete M Circulation; 1992 Mar; 85(3):928-34. PubMed ID: 1537129 [TBL] [Abstract][Full Text] [Related]
12. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases]. Murakoshi T Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism. van Hulsteijn H; Briët E; Koch C; Hermans J; Bertina R Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602 [TBL] [Abstract][Full Text] [Related]
15. Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase. Rapold HJ; Grimaudo V; Declerck PJ; Kruithof EK; Bachmann F Blood; 1991 Sep; 78(6):1490-5. PubMed ID: 1832058 [TBL] [Abstract][Full Text] [Related]
16. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions. Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792 [TBL] [Abstract][Full Text] [Related]
17. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872 [TBL] [Abstract][Full Text] [Related]
18. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. Gallino A; Haeberli A; Baur HR; Straub PW Circulation; 1985 Jul; 72(1):27-30. PubMed ID: 2408785 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Kaplan KL; Nossel HL; Drillings M; Lesznik G Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721 [TBL] [Abstract][Full Text] [Related]
20. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism. Yudelman I Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]